INVA
Innoviva IncNASDAQ
Healthcare • Biotechnology
Updated 20 hours ago
Coverage ready
Factor tilt: Value-tilted Small Cap
$20.74-3.31%
Close Oct 13, 2026
- Market cap
- $1.53B
- 1 month
- -0.8%
- 3 months
- -5.3%
- 1 year
- +19.5%
- 52-week range
- $16.67$24.24
- Dividend, last 12 mo
- None in the last year
- Last ex-date
- Sep 8, 2015 · $0.25
- Next-quarter EPS estimate
- $0.34Quarter to Sep 30, 2026 · 5 analysts · revenue $115.31M
- Short interest
- 10.1% of float6.8M shares · settled Sep 30, 2026 · -4.2% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $443.43M
- Net income
- $357.24M
- Free cash flow
- $188.32M
- Book value
- $1.23B
- Total debt
- $269.66M
- P/E
- 4.3×
- Price / sales
- 3.5×
- Price / book
- 1.2×
- FCF yield
- +12.3%
- Net margin
- +80.6%
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if INVA is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
38 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 7
Largest 13-F holders · Q2 2026
307 filers reported a long position in INVA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $262.4M | 11.6M | +2.2% |
| DIMENSIONAL FUND ADVISORS LP | $102.1M | 4.5M | +1.3% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $95.8M | 4.2M | -0.1% |
| RENAISSANCE TECHNOLOGIES LLC | $91.7M | 4M | -0.5% |
| STATE STREET CORP | $74.2M | 3.3M | +6.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $71.7M | 3.2M | +0.5% |
| MILLENNIUM MANAGEMENT LLC | $57.7M | 2.5M | +11.5% |
| GEODE CAPITAL MANAGEMENT, LLC | $47.1M | 2.1M | +7.5% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $46M | 2M | 0% |
| Boston Partners | $43.8M | 1.9M | +12.2% |
Get the Full Analysis for INVA
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.